Exelixis
EXEL
#1818
Rank
โ‚ฌ8.80 B
Marketcap
31,47ย โ‚ฌ
Share price
-0.03%
Change (1 day)
66.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚ฌ8.80 Billion

As of February 2025 Exelixis has a market cap of โ‚ฌ8.80 Billion. This makes Exelixis the world's 1818th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ8.80 B-5.07%
2024โ‚ฌ9.27 B37.49%
2023โ‚ฌ6.74 B39.91%
2022โ‚ฌ4.82 B-5.56%
2021โ‚ฌ5.10 B0.88%
2020โ‚ฌ5.06 B5.92%
2019โ‚ฌ4.77 B-7.31%
2018โ‚ฌ5.15 B-31.21%
2017โ‚ฌ7.49 B82.4%
2016โ‚ฌ4.10 B249.5%
2015โ‚ฌ1.17 B406.97%
2014โ‚ฌ0.23 B-71.68%
2013โ‚ฌ0.81 B29.06%
2012โ‚ฌ0.63 B28.4%
2011โ‚ฌ0.49 B-26.73%
2010โ‚ฌ0.67 B21.51%
2009โ‚ฌ0.55 B46.4%
2008โ‚ฌ0.37 B-38.75%
2007โ‚ฌ0.61 B-5.44%
2006โ‚ฌ0.65 B-1.28%
2005โ‚ฌ0.66 B26.28%
2004โ‚ฌ0.52 B31.56%
2003โ‚ฌ0.39 B-12.16%
2002โ‚ฌ0.45 B-56.99%
2001โ‚ฌ1.05 B45.65%
2000โ‚ฌ0.72 B

End of Day market cap according to different sources

On Feb 12th, 2025 the market cap of Exelixis was reported to be:

โ‚ฌ8.98 Billion
by Nasdaq info icon info icon
โ‚ฌ8.98 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ8.98 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ70.74 B 703.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ131.25 B 1,390.09%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ207.93 B 2,260.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ109.33 B 1,141.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ152.18 B 1,627.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ358.66 B 3,971.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ138.49 B 1,472.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.75 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.50 B-94.32%๐Ÿ‡บ๐Ÿ‡ธ USA